Hemp in Flux: The European Union’s Winding Road to Regulation

Written by Darren Kaplan, Associate Attorney The European Commission continues to waiver in deciding how it will treat products containing hemp-derived cannabidiol (“CBD”) in the European Union, leaving some hemp companies in flux about the long-term legality of their operations. Consumer Demand Outpacing Laws and Regulations As in the rest of the world, European consumer

By |2020-09-22T14:35:05-06:00September 22nd, 2020|Hemp|

How GW Pharma Won CBD

GW Pharma's CBD Success As of this writing, GW Pharma’s CBD drug Epidiolex has been approved for treating profound refractory pediatric epilepsy syndromes (Dravet syndrome and Lennox Gastaut syndrome) as well as seizures associated with tuberous sclerosis complex (TSC) in patients one year of age or older.  The product is a very simple, orally-administered formulation

By |2020-09-22T13:47:16-06:00September 21st, 2020|Regulatory|

CannaAfrica: Cannabis & CBD Investment

Written By: Dr. Solomon Alieu Villa-Squire Recently, west Africa has begun cultivating cannabis in large quantities in a quality controlled environment. IKYLINKS Inc. LLC a.k.a. CannaAfrica is ready to advance cultivation in Ghana, Liberia, Sierra Leone, where our companies register. Cannabis In Africa CannaAfrica is continuing to research the market in Nigeria, Mali, Guinea, Egypt,

By |2020-09-10T13:07:29-06:00September 10th, 2020|HLG Global|

The Best Hoban Minute Podcasts on CBD

CBD News is Frequently a Topic of Choice - Here's the Best of the Best Over the course of the first 100 episodes of The Hoban Minute, Bob and Eric have spoken with leaders of the CBD and cannabinoid industry in the U.S. and around the world. These conversations have touched on every part of

By |2020-08-11T15:31:04-06:00August 10th, 2020|News and Events|

Cannabinoids Molecules in Motion

Written By Dennis Brovarone Most people interested in cannabis have learned there are over one hundred different molecules known as “cannabinoids” found in cannabis flowers with THC ( tetrahydrocannabinol) and CBD (cannabidiol ) being the best known while CBN (cannabinol) rapidly attracting scientific research and consumer demand.  People are also aware that cannabinoids interact with the

By |2020-08-04T13:31:01-06:00August 4th, 2020|Uncategorized|

Hemp CBD vs Marijuana CBD: What’s the Difference?

Differences Between Marijuana CBD and Hemp CBD Cannabidiol (or “CBD” for short) has gained immense popularity on the market in the U.S. and beyond over the last several years. CBD is just one of the many naturally-occurring phytocannabinoids found in the cannabis plant. Unlike THC (tetrahydrocannabinol), which is typically associated with causing a “high” in

By |2020-09-04T10:34:41-06:00August 4th, 2020|Hemp|

What is a Cannabinoid?

Written By: Eric Singular Cannabis contains an array of unique chemicals, known as cannabinoids. The most prolific of these is tetrahydrocannabinol (THC), the psychoactive compound that legally distinguishes marijuana from industrial hemp. The other prominent cannabinoid, the one you’ve likely kept hearing about since the passage of the 2014 Farm Bill, is cannabidiol, better known

By |2020-08-04T13:01:37-06:00July 28th, 2020|Hemp|

The Hoban Minute – 95 | FoliuMed’s Oliver Zugel | How European Market Realities Differ from North America and Why it Matters

The Hoban Minute - 95 | FoliuMed’s Oliver Zugel | How European Market Realities Differ from North America and Why it Matters Bob and Eric sit down with the Founder and CEO of FoliuMed Holdings, Oliver Zugel to discuss the recent news that the European Commission is considering labeling CBD as a narcotic rather than

By |2020-07-28T11:07:09-06:00July 28th, 2020|The Hoban Minute|
Go to Top